Form 3 Filing - Axel Paeger Director Ownership Statement for Anavex Life Sciences Corp.

This is a Form 3 filing by Axel Paeger, a director of Anavex Life Sciences Corp. (AVXL), reporting his initial statement of beneficial ownership of securities. Filed on May 1, 2026, with a reporting period ending February 23, 2026, the document indicates that Paeger currently owns no securities in the company. The filing is required under Section 16(a) of the Securities Exchange Act of 1934 for directors, officers, and principal shareholders to disclose their ownership positions. As a director, Paeger is subject to these reporting requirements, and this Form 3 establishes his baseline ownership position with the company. The filing shows that while he holds a director position, he does not currently have any equity ownership in Anavex Life Sciences Corp., which is a biopharmaceutical company focused on developing treatments for neurodegenerative and neurodevelopmental diseases.